Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MDM2 | Q00987 | 6/20 | 0.58 |
| ▸ | MDM4 | O15151 | 2/20 | 0.51 |
| ▸ | TP53 | P04637 | 2/20 | 0.51 |
| ▸ | TLR2 | O60603 | 2/20 | 0.50 |
| ▸ | CASP3 | P42574 | 1/20 | 0.48 |
| ▸ | IDO1 | P14902 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28124458 | 0.98 | MDM2 (0.58) | MDM2MDM4TP53TLR2CASP3 | |
| SCHEMBL29851790 | 0.98 | MDM2 (0.58) | MDM2MDM4TP53TLR2CASP3 | |
| SCHEMBL16059782 | 0.92 | MDM2 (0.55) | MDM2MDM4TP53TLR2CASP3 | |
| SCHEMBL6740719 | 0.90 | MDM2 (0.57) | MDM2MDM4TP53TLR2CASP3 | |
| SCHEMBL28928924 | 0.90 | MDM2 (0.57) | MDM2MDM4TP53TLR2CASP3 | |
| SCHEMBL34468451 | 0.89 | MDM4 (0.54) | MDM2MDM4TP53CASP3IDO1 | |
| SCHEMBL15630864 | 0.89 | MDM4 (0.54) | MDM2MDM4TP53CASP3IDO1 | |
| SCHEMBL15630865 | 0.89 | MDM4 (0.54) | MDM2MDM4TP53CASP3IDO1 | |
| SCHEMBL20211701 | 0.89 | MDM4 (0.54) | MDM2MDM4TP53CASP3IDO1 | |
| SCHEMBL25357881 | 0.88 | MDM2 (0.58) | MDM2MDM4TP53TLR2CASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4169944-A1 | PROCESS FOR PREPARING HYBRID IMMUNOGLOBULIN CONTAINING NON-PEPTIDYL LINKAGE | Biomolecular Holdings LLC (US) | 2023-04-26 | — | — | EP | disclosed |
| EP-3701971-B1 | COMPOUNDS USEFUL IN PREPARING HYBRID IMMUNOGLOBULIN CONTAINING NON-PEPTIDYL LINKAGE | BIOMOLECULAR HOLDINGS LLC (US) | 2022-07-06 | — | — | EP | disclosed |
| EP-3611180-B1 | HYBRID IMMUNOGLOBULIN CONTAINING NON-PEPTIDYL LINKAGE | BIOMOLECULAR HOLDINGS LLC (US) | 2021-12-22 | — | — | EP | disclosed |
| EP-3701971-A1 | COMPOUNDS USEFUL IN PREPARING HYBRID IMMUNOGLOBULIN CONTAINING NON-PEPTIDYL LINKAGE | Capon, Daniel J. (US) | 2020-09-02 | — | — | EP | disclosed |
| EP-3611180-A1 | HYBRID IMMUNOGLOBULIN CONTAINING NON-PEPTIDYL LINKAGE | Capon, Daniel J. (US) | 2020-02-19 | — | — | EP | disclosed |
| EP-3116486-A2 | HYBRID IMMUNOGLOBULIN CONTAINING NON-PEPTIDYL LINKAGE | Capon, Daniel J. (US) | 2017-01-18 | — | — | EP | disclosed |
| EP-2968495-A2 | HYBRID IMMUNOGLOBULIN CONTAINING NON-PEPTIDYL LINKAGE | Capon, Daniel J. (US) | 2016-01-20 | — | — | EP | disclosed |
| WO-2015138907-A2 | HYBRID IMMUNOGLOBULIN CONTAINING NON-PEPTIDYL LINKAGE | CAPON DANIEL J (US) | 2015-09-17 | — | — | WO | disclosed |
| WO-2014144911-A2 | HYBRID IMMUNOGLOBULIN CONTAINING NON-PEPTIDYL LINKAGE | CAPON DANIEL J (US) | 2014-09-18 | — | — | WO | disclosed |